en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanish

Office of the Vermont Attorney General

Holding Industry Accountable

The Attorney General’s Office is committed to leading the fight to end the opioid crisis. Our office has been taking part in a multi-state investigation involving 44 other states and the District of Columbia. This investigation has focused on whether drug manufacturers such as Purdue Pharma, Endo, Janssen, Teva/Cephalon, and Allergan have engaged in unlawful practices in marketing, selling, and distributing opioids. We are also investigating the drug distributors AmerisourceBergen, Cardinal Health, and McKesson.

On September 5, 2018, the Attorney General sued Purdue Pharma for deception and unfairness under the Vermont Consumer Protection Act and under Vermont’s public nuisance law. Investigations against other drug manufacturers and drug distributors continue.

On March 26, 2019, Attorney General Donovan brought suit against two distributors of opioids: McKesson Corporation and Cardinal Health Inc.  The State’s lawsuit alleges that Defendants’ systems were wholly inadequate to fulfill their legal duty to monitor and control the sale of opioids. A copy of the complaint may be found here.